KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Gains from Sales and Divestitures: 2023-2024

  • Opko Health's Gains from Sales and Divestitures changed negligibly% to $549,687 in Q4 2024 from the same period last year, while for Dec 2024 it was $549,687, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $549,687 for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q4 2024, Opko Health's Gains from Sales and Divestitures stood at $549,687, which was up 0.00% from $549,680 recorded in Q4 2023.
  • In the past 5 years, Opko Health's Gains from Sales and Divestitures registered a high of $549,687 during Q4 2024, and its lowest value of $549,680 during Q4 2023.
  • Moreover, its 2-year median value for Gains from Sales and Divestitures was $549,684 (2023), whereas its average is $549,684.
  • Data for Opko Health's Gains from Sales and Divestitures shows a peak YoY increased of 0.00% (in 2024) over the last 5 years.
  • Quarterly analysis of 2 years shows Opko Health's Gains from Sales and Divestitures stood at $549,680 in 2023, then rose by 0.00% to $549,687 in 2024.